|
2-((3-甲氧基苯基)硫基)乙酸
|
T699151-100mg
|
≥97% |
3996-32-5 |
100mg
|
¥ 184.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,5-二甲基苯基硫脲
|
T699148-5g
|
≥97% |
16738-19-5 |
5g
|
¥ 5307.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,5-二甲基苯基硫脲
|
T699148-250mg
|
≥97% |
16738-19-5 |
250mg
|
¥ 526.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,5-二甲基苯基硫脲
|
T699148-1g
|
≥97% |
16738-19-5 |
1g
|
¥ 1571.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-硫代-1,2-二氢吡啶-4-羧酸
|
T699144-1g
|
≥95% |
18616-05-2 |
1g
|
¥ 2587.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,3,6-三氯-5-甲基吡啶
|
T699142-1g
|
≥95% |
58584-95-5 |
1g
|
¥ 4377.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-苯甲硫基-1,3,4-噻二唑-2-硫醇
|
T699079-100mg
|
≥95% |
4858-36-0 |
100mg
|
¥ 243.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5',6',7',8'-tetrahydro-3'H-spiro[cyclohexane-1,4'-quinazoline]-2'-thiol
|
T699068-250mg
|
≥97% |
5579-43-1 |
250mg
|
¥ 1771.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5',6',7',8'-tetrahydro-3'H-spiro[cyclohexane-1,4'-quinazoline]-2'-thiol
|
T699068-1g
|
≥97% |
5579-43-1 |
1g
|
¥ 5869.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5',6',7',8'-tetrahydro-3'H-spiro[cyclohexane-1,4'-quinazoline]-2'-thiol
|
T699068-100mg
|
≥97% |
5579-43-1 |
100mg
|
¥ 1042.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4,5,6,7-四氢-1h-吲哚-2-羧酸
|
T699019-250mg
|
≥98% |
131172-64-0 |
250mg
|
¥ 1513.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4,5,6,7-四氢-1h-吲哚-2-羧酸
|
T699019-1g
|
≥98% |
131172-64-0 |
1g
|
¥ 4903.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4,5,6,7-四氢-1h-吲哚-2-羧酸
|
T699019-100mg
|
≥98% |
131172-64-0 |
100mg
|
¥ 860.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1-(4-甲氧基苄基)-2-硫脲
|
T699005-10g
|
≥98% |
37412-64-9 |
10g
|
¥ 5197.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,5,7-三甲基喹啉-8-醇
|
T698994-2g
|
≥95% |
6759-80-4 |
2g
|
¥ 2563.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-(3,4-二甲氧基苄基)-1,3,4-噻二唑-2-胺
|
T698964-100mg
|
≥95% |
313957-85-6 |
100mg
|
¥ 40.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-(2-氟苯基)-3-胺基硫脲
|
T698943-5g
|
≥96% |
38985-72-7 |
5g
|
¥ 1248.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[2-(三氟甲基)]苯基硫脲
|
T698942-5g
|
≥97% |
1736-71-6 |
5g
|
¥ 843.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[2-(三氟甲基)]苯基硫脲
|
T698942-25g
|
≥97% |
1736-71-6 |
25g
|
¥ 3210.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[2-(三氟甲基)]苯基硫脲
|
T698942-1g
|
≥97% |
1736-71-6 |
1g
|
¥ 219.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-(4-(4-氟苯基)噻唑-2-基)乙酰胺
|
T698939-250mg
|
≥97% |
342405-30-5 |
250mg
|
¥ 3786.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-(4-(4-氟苯基)噻唑-2-基)乙酰胺
|
T698939-1g
|
≥97% |
342405-30-5 |
1g
|
¥ 12551.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-(4-(4-氟苯基)噻唑-2-基)乙酰胺
|
T698939-100mg
|
≥97% |
342405-30-5 |
100mg
|
¥ 2226.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-(9H-芴)-1,3-噻唑-2-胺
|
T698925-5g
|
≥95% |
299438-56-5 |
5g
|
¥ 6045.9
|
期货,请咨询 |
|
0 |
阿拉丁 |